Navigation Links
Translational Sciences Corporation to Launch OncoTrac™ at the American Society of Clinical Oncology (ASCO) Annual Meeting

BOSTON and CHICAGO, June 1, 2011 /PRNewswire/ -- Translational Sciences Corp. (TSC) will launch OncoTracfor Clinical Research at the America Society of Clinical Oncology (ASCO), June 4-6, at Chicago's McCormick Place, Booth #22114. The OncoTrac™ family of software products provides a structured workflow solution for clinicians to report precise measurement of solid and metastatic tumor progression.

OncoTrac™ for Clinical Research enterprise software facilitates tumor response assessment using widely accepted standards such as RECIST 1.0, RECIST 1.1, and WHO, as well as emerging standards such as the Choi criteria. Assessments using these criteria are commonly required by clinical trial protocols and are often submitted as primary and secondary end-point data in new anti-cancer FDA drug approval applications. Yet, not all clinical cancer research reports tumor response correctly with regard to these standards. OncoTrac™is designed to assure conformity to these standards and aid compliance with established clinical research standards including FDA Good Clinical Practice (GCP) and Part 11 Electronic Medical Records. Subject assessment data are integrated into existing research workflows, thereby providing capabilities comparable to those performed at core imaging laboratories in support of drug applications.

Medical imaging techniques such as CT and MRI produce very large data sets that are typically displayed as images and read by clinicians. Often times, subtle but clinically significant findings can be difficult to visualize and computational analysis has been demonstrated to assist precise identification or measurement of disease. The routine implementation of RECIST as a research standard is a clear example,” said Howard Pinsky, CEO of Translational Sciences Corp.  “Recently, the Radiological Society of North America (RSNA), the world’s largest professional radiology society, has made a significant commitment to the integration of quantitative imaging into radiology practice -- an ambitious goal requiring development and deployment of dedicated software like OncoTrac™.”


Headquartered in Cambridge, Massachusetts, Translational Sciences Corp. (TSC) is a medical software company dedicated to adding value to medical imaging studies, increasing physician efficiency, and improving patient management.Contact:

Anthony Grise +1.877.219.3940

SOURCE Translational Sciences Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Translational Science Expert, Dr. Melissa Ashlock, Joins aTyr Pharma to Advance Physiocrine-based Therapeutics
2. Janet Hammond Joins Roche as Vice President, Translational Medicine - Virology
3. AndroScience Corporation Awarded a $3.8 Million, 3-Year Milestone-Driven, Cooperative Translational Research Grant from the NIH to Develop an Oral Treatment for Spinal Bulbar Muscular Atrophy (Kennedys Disease)
4. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
5. Childrens Hospital Boston and Particle Sciences Cooperate on Translational Medicine Efforts
6. Mike Burgess Named Head of Oncology Discovery Translational Area for Roches Pharma Research and Early Development (pRED) Organization
7. The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies
8. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
9. Adlyfe Strikes Translational Medicine Partnership With Wyeth Pharmaceuticals for Alzheimers Biomarker Assay
10. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
11. Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinsons Disease Research
Post Your Comments:
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):